Rena Conti

Determining drug value: Let’s start with the evidence

  • October 24, 2019

Last month, I was pleased to speak at the Institute for Health Policy forum that delved into a critical topic in the drug pricing dialogue: drug value. When I arrived in Washington, D.C., I was struck by how far we’ve…

Drug policy 101: Breaking down different types of drug products

  • October 22, 2019

As patients, providers, and health systems continue to grapple with unsustainably high drug prices in the United States, it is important for policymakers to understand the distinct differences between broad categories of therapies as they examine potential solutions.

Drug policy 101: The state of the pharmaceutical evidence base

  • September 26, 2019

Having sound evidence about a drug’s safety and effectiveness is critical to understanding its benefits and value. In recent years, shifts in the pharmaceutical evidence base have created challenges for evaluating drugs after they come to market.